Softwr

Healthcare · head to head

Cerner vs Lunit

Cerner logo

Cerner

Healthcare

Health information technology solutions for healthcare organizations

From
On request
Rated
-
Lunit logo

Lunit

Healthcare

FDA cleared and CE marked AI for mammography, tomosynthesis and chest radiography

From
On request
Rated
-

The short version

  • Each has a real cost: Cerner no published pricing on vendor website; enterprise healthcare software requires custom quotes; Lunit the regulatory permission differs by product and by region, and INSIGHT Risk has been filed with the FDA but not cleared, so a buyer who reads a corporate press release rather than the specific clearance for their product and jurisdiction will plan a deployment they cannot legally run.
  • They diverge on capability: Cerner covers Electronic Health Records, Lunit covers Lunit INSIGHT MMG.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Cerner and Lunit actually diverge.

Attributes where Cerner and Lunit differ
AttributeCernerLunit
PlatformsWeb, iOS, AndroidWeb
Founded1979Unknown

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Cerner

  • Electronic Health Records
  • Revenue Cycle
  • Population Health
  • Patient Engagement
  • HL7
  • FHIR
  • Lab Systems
  • HIPAA

Only in Lunit

  • Lunit INSIGHT MMG
  • Lunit INSIGHT DBT
  • Lunit INSIGHT CXR
  • Volpara density assessment
  • Volpara RiskPathways
  • Volpara dose tracking
  • PACS and mammography workstation integration

What people use each for

The jobs each tool is most often brought in to do.

Cerner

  • Hospital and acute care EHR for chart review and clinical documentationnot Lunit
  • Mobile clinical access for physicians and care teams on point-of-care devicesnot Lunit

Lunit

  • A national breast screening programme evaluating AI as a second reader to reduce double reading workload where two human readers are currently mandatednot Cerner
  • A breast centre that moved to tomosynthesis and now has reading times it cannot staff, wanting detection support on DBT specificallynot Cerner
  • An American breast imaging centre needing automated volumetric density assessment to meet patient density notification requirements, which is what Volpara is bought fornot Cerner
  • A tuberculosis or lung screening programme in a high volume, radiologist scarce setting using chest radiography triage to prioritise filmsnot Cerner

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Cerner

  • No published pricing on vendor website; enterprise healthcare software requires custom quotes

Lunit

  • The regulatory permission differs by product and by region, and INSIGHT Risk has been filed with the FDA but not cleared, so a buyer who reads a corporate press release rather than the specific clearance for their product and jurisdiction will plan a deployment they cannot legally run.
  • Detection AI changes recall rates in screening, and the downstream cost of additional diagnostic workup lands on the programme rather than on the software budget, which is the cost most screening business cases omit.
  • Performance is sensitive to the mammography vendor and acquisition protocol, so published results from a Hologic estate do not transfer to a GE or Siemens estate without local validation the buyer must fund.
  • MMG, DBT and CXR are licensed separately and Volpara modules are separate again, so a breast centre wanting detection, density and risk pathways is assembling four line items rather than buying one product.
  • Using AI as a replacement for one of two human readers is a workforce and liability decision that regulators and professional bodies treat differently in each country, so the saving that justifies the purchase may not be permitted where you operate.

Pricing, plan by plan

Cerner

On request

No published plan breakdown. See the Cerner review.

Lunit

On request
  • Lunit INSIGHT$undefined/year
    • Priced per study or per annual examination volume by product
    • MMG, DBT and CXR licensed separately
    • Volpara density and RiskPathways modules quoted separately

Which should you pick?

Choose Cerner if

  • You need electronic health records.
  • You work on Web, iOS, Android.
  • You also want revenue cycle.

Choose Lunit if

  • You need lunit insight mmg.
  • You also want lunit insight dbt.

Questions people ask

Is Cerner or Lunit better?
Neither clearly leads. Cerner starts at On request and Lunit at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Cerner or Lunit?
Cerner starts at On request and Lunit at On request.
Does Cerner or Lunit run on more platforms?
Cerner runs on Web, iOS, Android. Lunit runs on Web.
What is Cerner best used for?
Cerner is most often used for hospital and acute care ehr for chart review and clinical documentation, mobile clinical access for physicians and care teams on point-of-care devices. Of those, hospital and acute care ehr for chart review and clinical documentation and mobile clinical access for physicians and care teams on point-of-care devices are not what Lunit is typically brought in for.
What can Cerner do that Lunit cannot?
Cerner covers Electronic Health Records, Revenue Cycle, Population Health, Patient Engagement. Lunit covers Lunit INSIGHT MMG, Lunit INSIGHT DBT, Lunit INSIGHT CXR, Volpara density assessment.

Answered from the vendors’ own pages

Cerner: Does Cerner publish its pricing?

No, Cerner does not publish standard pricing. As an enterprise healthcare EHR vendor (now acquired by Oracle), pricing is customized per healthcare organization based on size, bed capacity, modules required, and implementation scope. Contact Oracle Health for pricing.

Source
Lunit: Is Lunit FDA cleared?

Yes for specific products. INSIGHT MMG, INSIGHT DBT and INSIGHT CXR Triage hold FDA 510(k) clearances. INSIGHT Risk, the five year risk prediction model, has been filed but was not cleared at the time of writing.

Lunit: Can Lunit replace a second human reader in screening?

That depends entirely on your jurisdiction and professional body guidance, not on the software. The CE mark permits clinical use; it does not authorise a workforce model.

Lunit: What did the Volpara acquisition add?

Volumetric breast density measurement, dose tracking and RiskPathways high risk programme management, which are the things American breast centres buy for density notification compliance rather than for detection.

Lunit: Is pricing published?

No. It is quoted per study or per annual volume, by product, with on premises and cloud priced differently.

Share

Related pages

Other head to heads